The Pfizer state laboratory, which together with the German company BioNTech produces the first vaccine against covid-19 approved for its commercialization in the European Union, has announced this year a temporary descent and the envoy of its vials to the distant European countries proxim semana. Pfizer explained in a statement, quoted by Reuters, that it has made modifications to the production process and installations that require additional authorizations. “Although it is affecting the enrollment of the February finals in February, a significant increase in the available doses in the February and March finals has been added,” he added.
The Institute of Public Health of Norway has informed this notice when it receives a message from the pharmaceutical company stating that it has reduced a reduction from 43,875 to 36,075 in the dose provided for its admission (17.7%). Although Norway is not a Member State of the EU, the note published by the Health Institute of this country states: “Temporal reduction will affect all European countries”. A spokesman for the Lithuanian Ministry of Health, which is part of the EU, has confirmed to Reuters the announcement of these reports.
The vacancy of Pfizer and BioNTech will be inoculated in the EU’s public from 27 December 2020 and is, until the end, the great crisis of Brussels: the European Commission’s Vacancy Strategy has centralized the purchase of Has 600 million doses of this pharmacy to distribute between the 27 paisas of the community club. Spain is expected to receive a maximum of 4.5 million injections from this company during the first 12 weeks of the holiday campaign, some 375,000 each day. A similar reduction to Norway up to 66,000 less per week.
This week also received in Spain the first doses of the vaccine of Moderna, per 35 million, a quantity that should be increased, inform Emilio de Benito. And in the end, it is hoped that the Commission will approve the Oxford agreement with which the summit will be approved. Precisely to avoid these vacancies it is because the EU has reserved 2,000 million doses of manufacturers, of which Spain has a corresponding correspondence of 10% depending on its population.
According to the document published by the Norwegian authorities, the report calls for a reorganization of the production of the pharmaceutical company, while the latter agrees to increase the manufacturing capacity in the future. Pfizer is about to increase its production capacity with the goal of producing 1,300 million annual vacancies to 2,000 million annual doses. “Everything is not exactly clear at this time when Pfizer wants to increase the maximum production capacity,” he added.
The notice is given when in Spain the eviction process is also being improved through one of its titanium holdings. The municipalities, according to the data of the Ministry of Health of these juveniles, injecting so many doses in one day (94,548 these juveniles) as hiccups in the first week (99,753), and when the Municipality of the municipalities reduced the amount of dose that guard for the uninitiated.
The Ministry of Health has stated that it is in direct contact with the European Commission (which has signed the Compra Anticipada contract with Pfizer-BioNTech), the rest of the member states and with the maximum responsibility of Pfizer to mitigate the impact of the reduction that has announced the company. As long as the dose number is defined as the places are communicated to those responsible for the health of the communities and autonomous cities in order to be able to adapt the evacuation strategy according to this situation ”.
Coronavirus Information
Here you can follow the ultimate time regarding the evolution of the pandemic
– Restriction Searcher: What can I do in my municipality?
– Asia evolves the coronavirus curve in the world
– Descárguese the application of rastreo for Spain
– Actuation guide prior to transmission